Accent Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Accent Therapeutics's estimated annual revenue is currently $3.4M per year.
- Accent Therapeutics's estimated revenue per employee is $77,500
- Accent Therapeutics's total funding is $178M.
Employee Data
- Accent Therapeutics has 44 Employees.
- Accent Therapeutics grew their employee count by -41% last year.
Accent Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Business Officer | Reveal Email/Phone |
3 | VP, Biological & Translational Sciences | Reveal Email/Phone |
4 | VP, Chemistry | Reveal Email/Phone |
5 | VP Pre-Clinical Development | Reveal Email/Phone |
6 | VP Program Leadership | Reveal Email/Phone |
7 | VP Translational Medicine | Reveal Email/Phone |
8 | VP Biology | Reveal Email/Phone |
9 | SVP, Molecular Discovery | Reveal Email/Phone |
10 | VP Finance | Reveal Email/Phone |
Accent Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is Accent Therapeutics?
Leading the translation of RNA-modifying protein (RMP) biology into promising new therapies for cancer.
keywords:N/A
$178M
Total Funding
44
Number of Employees
$3.4M
Revenue (est)
-41%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Accent Therapeutics News
Revolution Labs will be the new home for Accent Therapeutics, which has committed to a 65k SF lease for its innovative cancer research...
Some of the players operating in the global RNA-targeted small molecules market are: ACCENT THERAPEUTICS, Anima Biotech Inc.,...
Accent Therapeutics, a Lexington, MA-based biopharmaceutical company developing breakthrough treatments for cancer patients, completed a $63m Series B financing. The round was led by EcoR1 Capital with participation by GV, AbbVie Ventures, The Mark Foundation for Cancer Research, NS Investment ...
Biopharmaceutical company Accent Therapeutics announced it has raised $63 million in Series B funding Biopharmaceutical company Accent Therapeutics announced it has raised $63 million in Series B funding led by EcoR1 Capital with participation by GV, AbbVie Ventures, The Mark Foundation for Can ...
Two years ago, Accent Therapeutics got off a $40 million series A to target RNA-modifying proteins in cancer; now, in the middle of a pandemic, it’s still managed to bring in a respectable $63 million second funding round. Sponsored by Agilent Technologies How would you like to win free bench ...
Other Companies in Lexington
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.5M | 44 | 10% | N/A |
#2 | $10.2M | 44 | 10% | N/A |
#3 | $10.2M | 44 | 19% | N/A |
#4 | $5.1M | 44 | -19% | N/A |
#5 | $35M | 44 | 2% | N/A |